tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CHGCF Stock Latest News

Chugai’s DONQ52 Celiac Study Advances, Adding a New Mid‑Stage Catalyst for CHGCF
Company AnnouncementsChugai’s DONQ52 Celiac Study Advances, Adding a New Mid‑Stage Catalyst for CHGCF
3d ago
CHGCF
Chugai Pharmaceutical Completes Absorption-Type Merger of Renalys Pharma
PremiumCompany Announcements
Chugai Pharmaceutical Completes Absorption-Type Merger of Renalys Pharma
12d ago
Chugai Highlights Positive Phase 3 Results and FDA Filing for Lilly’s Oral GLP-1 Orforglipron
PremiumCompany Announcements
Chugai Highlights Positive Phase 3 Results and FDA Filing for Lilly’s Oral GLP-1 Orforglipron
24d ago
Chugai Pharmaceutical to Merge with Renalys Pharma to Boost Kidney Disease Drug Development
PremiumCompany Announcements
Chugai Pharmaceutical to Merge with Renalys Pharma to Boost Kidney Disease Drug Development
2M ago
Chugai Pharmaceutical’s Promising Phase III Study on Ulcerative Colitis Treatment
PremiumCompany Announcements
Chugai Pharmaceutical’s Promising Phase III Study on Ulcerative Colitis Treatment
3M ago
CHGCF
Chugai Pharmaceutical Advances Satralizumab Trial for Autoimmune Encephalitis
PremiumCompany AnnouncementsChugai Pharmaceutical Advances Satralizumab Trial for Autoimmune Encephalitis
3M ago
CHGCF
Chugai Pharmaceutical’s Satralizumab Study: A Potential Game-Changer for MOGAD Treatment?
Premium
Company Announcements
Chugai Pharmaceutical’s Satralizumab Study: A Potential Game-Changer for MOGAD Treatment?
3M ago
CHGCF
Chugai’s Phase III Study on Divarasib: A Potential Game-Changer in Lung Cancer Treatment
Premium
Company Announcements
Chugai’s Phase III Study on Divarasib: A Potential Game-Changer in Lung Cancer Treatment
3M ago
CHGCF
Chugai Pharmaceutical’s Promising Phase III Study on Crohn’s Disease Treatment
PremiumCompany Announcements
Chugai Pharmaceutical’s Promising Phase III Study on Crohn’s Disease Treatment
3M ago
CHGCF
Chugai Pharmaceutical’s Promising Phase III Study on Crohn’s Disease Treatment
PremiumCompany Announcements
Chugai Pharmaceutical’s Promising Phase III Study on Crohn’s Disease Treatment
3M ago
CHGCF
Chugai’s Promising Lung Cancer Study: A Potential Game-Changer?
PremiumCompany Announcements
Chugai’s Promising Lung Cancer Study: A Potential Game-Changer?
3M ago
CHGCF
Chugai Pharmaceutical’s AUBE00 Study: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
Chugai Pharmaceutical’s AUBE00 Study: A Potential Game-Changer in Cancer Treatment
3M ago
CHGCF
Chugai Pharmaceutical’s New Phase I Trial: A Potential Game-Changer in Lung Cancer Treatment
PremiumCompany AnnouncementsChugai Pharmaceutical’s New Phase I Trial: A Potential Game-Changer in Lung Cancer Treatment
3M ago
CHGCF
Chugai’s RAINBOW-LTE Trial: A Promising Step in Immunological Disease Treatment
Premium
Company Announcements
Chugai’s RAINBOW-LTE Trial: A Promising Step in Immunological Disease Treatment
3M ago
CHGCF
Chugai’s RAINBOW Trial: A New Hope in Immunological Disease Treatment
Premium
Company Announcements
Chugai’s RAINBOW Trial: A New Hope in Immunological Disease Treatment
3M ago
CHGCF
Chugai Pharmaceutical’s Promising Phase I Study on ROSE12 for Solid Tumors
PremiumCompany Announcements
Chugai Pharmaceutical’s Promising Phase I Study on ROSE12 for Solid Tumors
3M ago
CHGCF
Chugai Pharmaceutical Acquires Renalys Pharma to Expand IgA Nephropathy Treatment
PremiumCompany Announcements
Chugai Pharmaceutical Acquires Renalys Pharma to Expand IgA Nephropathy Treatment
3M ago
Chugai Pharmaceutical Reports Strong Q3 Results and Announces Special Dividend
PremiumCompany Announcements
Chugai Pharmaceutical Reports Strong Q3 Results and Announces Special Dividend
3M ago
Chugai Pharmaceutical’s Role in Roche’s Q3 2025 Sales Announcement
PremiumCompany Announcements
Chugai Pharmaceutical’s Role in Roche’s Q3 2025 Sales Announcement
3M ago
CHGCF Earnings this Week: How Will it Perform?
PremiumPre-EarningsCHGCF Earnings this Week: How Will it Perform?
3M ago
Chugai Partners with Rani Therapeutics for Innovative Oral Biologics
Premium
Company Announcements
Chugai Partners with Rani Therapeutics for Innovative Oral Biologics
3M ago
Eli Lilly’s Orforglipron Shows Superior Results in Diabetes Trial
Premium
Company Announcements
Eli Lilly’s Orforglipron Shows Superior Results in Diabetes Trial
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >